Skip to main content
Equibles
TRLV logo

TRLV · Trulieve Cannabis Corp. · Metrics

Track TRLV — free

Use TRLV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TRLV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.47 -0.20 (-1.87%) Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$2.05B
Shares
192.57M
Volume · Oct 28 790.05K Avg daily vol (3M) 1.68M

TRLV metrics

85 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$10.67
Market cap
$2.05B

Price action

20 metrics
Price change (1W)
-1.1%
Price change (30D)
-13.5%
Price change (3M)
+28.1%
Price change (6M)
+5.9%
Price change (YTD)
+22.8%
Price change (1Y)
+45.6%
Trailing year
Price change (5Y)
-57.4%
52-week high
$13.00
52-week low
$4.76
Change from 52-week high
-17.9%
Change from 52-week low
+124.2%
Annualized volatility
110.2%
Annualized volatility (3M)
57.0%
Beta
0.9
RSI (14D)
48.4
Price vs SMA 50
-4.4%
Price vs SMA 200
+21.3%
Avg volume (3M)
1.68M
Relative volume
0.5
Average dollar volume
$18.42M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
192.57M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.7×
reciprocal yield 58.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.8×
reciprocal yield 55.1%
P / book
2.7
reciprocal yield 37.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
8.5
reciprocal yield 11.8%
Earnings yield
-23.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.2×
reciprocal yield 81.4%
EV / revenue historical average (5Y)
1.5×
reciprocal yield 66.1%
EV / EBIT historical average (3Y)
11.1×
reciprocal yield 9.0%
EV / EBIT historical average (5Y)
22.0×
reciprocal yield 4.5%
EV / EBITDA historical average (3Y)
6.4×
reciprocal yield 15.7%
EV / EBITDA historical average (5Y)
8.6×
reciprocal yield 11.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-05
Last earnings
2026-08-07

Profitability

9 metrics
Gross margin
59.5%
Operating margin
-24.3%
Trailing 12 months
Net margin
-41.8%
Gross profit (TTM)
$677.39M
Operating profit (TTM)
−$277.26M
Net income (TTM)
−$476.16M
Trailing 12 months
Diluted EPS (TTM)
$-0.79
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$5.89
Gross profit per diluted share (TTM)
$3.50
Operating profit per diluted share (TTM)
$-1.44
EBITDA per diluted share (TTM)
$-0.85
Net income per diluted share (TTM)
$-2.47
Operating cash flow per diluted share (TTM)
$1.27
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.11
Book value per share
$3.98

Growth

11 metrics
Revenue growth YoY
-10.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.14B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
-1.0%
Revenue CAGR (5Y)
+17.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-62.2%
Return on assets
-22.9%
Debt / equity
0.3
Current ratio
5.9
EBITDA (TTM)
−$162.92M
Free cash flow (TTM)
—
Quick ratio
4.0
Interest coverage
-4.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$129.60M
Latest balance sheet
Cash & equivalents
$325.42M
Total assets
$2.08B
Total debt
$195.82M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$244.44M
Capital expenditures (TTM)
$50.23M
R&D (TTM)
—
SG&A (TTM)
$431.99M
Stock compensation (TTM)
$20.81M
R&D / revenue
—
Stock compensation / revenue
1.8%

Ownership (13F)

9 metrics
13F filers
126
13F filer change QoQ
+120
Institutional ownership
18.2%
Conviction holders (share of 13F filers)
0.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+18,710.7%
Holder tenure
1.0
Price vs estimated holder cost
+9.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
3.8%
Latest settlement · 4.5 days to cover
Days to cover
4.5d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1754195 CUSIP 89790E106 13F (30d) 34 filings 34 filers Visit website Investor relations